As of 2024-12-15, the Intrinsic Value of Bright Minds Biosciences Inc (DRUG.CN) is
-2.56 CAD. This DRUG.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 58.37 CAD, the upside of Bright Minds Biosciences Inc is
-104.38%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-2.56 CAD
Intrinsic Value
DRUG.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
Fair Value |
-2.56 - -2.56 |
-2.56 |
-104.38% |
P/E |
58.39 - 58.39 |
58.39 |
0.0% |
DDM - Stable |
(0.06) - (0.10) |
(0.08) |
-100.1% |
DDM - Multi |
(0.06) - (0.07) |
(0.07) |
-100.1% |
DRUG.CN Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
405.67 |
Beta |
77.87 |
Outstanding shares (mil) |
6.95 |
Enterprise Value (mil) |
399.50 |
Market risk premium |
5.10% |
Cost of Equity |
512.45% |
Cost of Debt |
5.00% |
WACC |
258.07% |